April 19, 2025 - 20:08

In a recent statement, Mayor Eric Adams expressed strong disapproval of Public Advocate Jumaane Williams' proposal aimed at addressing the mental health crisis in New York City. Williams suggested that the state should initiate a rarely utilized review process to examine the police-involved shooting of a 61-year-old man with mental health issues in Queens.
Mayor Adams contended that the approach is misguided and fails to address the underlying issues contributing to the mental health crisis in the city. He emphasized the need for practical solutions that prioritize support and resources for individuals struggling with mental illness, rather than focusing solely on punitive measures against law enforcement.
The mayor's criticism highlights a growing tension between different approaches to handling mental health and public safety, as city officials grapple with the complexities of these intertwined issues. As New York City continues to seek effective strategies for addressing mental health, the debate over the best methods remains a critical topic of discussion among leaders.
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...
July 20, 2026 - 11:31
Seven peptides are under review by an FDA panel this week. Here’s everything we knowA federal advisory committee is set to meet this week to evaluate seven peptide products, a move that could reshape how these compounds are made and prescribed in the United States. The panel,...